[Therapy of essential arterial hypertension. V].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003000:Clonidine / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006145:Guanethidine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use*; D012110:Reserpine / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008750:Methyldopa; D012110:Reserpine; D003000:Clonidine; D006145:Guanethidine
Terapia dell'ipertensione arteriosa essenziale. Parte v.